Abnormality of the immune system may play an important role in the pathogenesis of schizophrenia (SCZ). We aim to investigate the relationship between clinical features of SCZ and tumor necrosis factor-alpha (TNF-α) −238 G/A, −308 G/A polymorphisms in SCZ patients by comparing genotype distributions of TNF-α gene polymorphisms between patients and healthy controls. A sample of 113 patients with SCZ and 104 healthy volunteers was included in the study. SCID-I was used to confirming the diagnosis according to DSM-IV-TR criteria. We evaluated the patients with some scales and data forms in terms of clinical features, symptom severity, level of insight, suicidal behavior, and treatment response. PCR-RFLP was used to determine TNF-α gene polymorphisms from DNA material. The distributions of TNF-α − 238 G/A and TNF-α − 308 G/A polymorphisms of the patients diagnosed with SCZ were not significantly different from the control group. There was a significant difference in the TNF-α − 238 G/A genotype distributions between treatment-resistant and treatment-responsive SCZ patients. Again, the distributions of TNF-α − 238 G/A genotype of attempted suicide patients in SCZ were significantly different from the non-attempted suicide of SCZ patients. Whereas TNF-α − 238 G/A and −308 G/A polymorphisms were not associated with SCZ, TNF-α − 238 G/A polymorphism may be related to treatment resistance and attempted suicide in SCZ patients in the Turkish population.

In this study, blood samples were taken from 200 patients with childhood acute leukaemias, including acute lymphoblastic leukaemia (ALL) and acute myeloid leukaemia (AML), and from 100 healthy volunteers (controls). The frequency of the human leucocyte antigen (HLA)-DRB1*04 allele was significantly higher, and the frequencies of the HLA-A23 and HLA-B7 antigens were significantly lower, in patients with ALL compared with controls. Among patients with AML, the frequency of the HLA-B49 antigen and the HLA-DRB1*15 allele were significantly higher, whereas the frequencies of the HLA-A11 and HLA-B38 antigens were significantly lower compared with controls. The frequency of the HLA-DRB1*04 allele was also significantly higher in male patients with ALL and AML, whereas the HLA-DRB1*13 allele was found significantly less frequently in male AML and female ALL patients than in controls. To date, this is the only study to evaluate the associations between HLA molecules and leukaemia in a Turkish population with acute childhood leukaemia.

In this study, the relation between emergency admissions for chronic obstructive pulmonary disease (COPD) at an Istanbul University Hospital between the years 1997 and 2001 and the meteorological and air pollution parameters has been analysed. Admissions were calculated for each month, and the relations between the number of admissions for each month and the corresponding month's meteorological parameters (pressure, temperature, moisture) and the average pollution values (CO, SO2, NO, NO2, PM10) were determined. There were 1586 patients included in this study. COPD admissions had a negative significant correlation with temperature (r =-0.72, p<0.001), a positive significant correlation with pressure (r=0.41, p=0.001) and humidity (r=0.34, p=0.007), and also had a positive significant correlation with SO2 (r=0.64, p<0.001), NO (r=0.40, p=0.002), CO (r=0.57, p<0.001) and PM10 (r=0.27, p=0.03). No significant relationship was found for NO2. When the meteorological and clinical parameters were evaluated, it was found that the only variable related to the COPD admissions was temperature. These results for COPD admissions were found to be considerably higher in seasons other than summer (p <0.001). When summer seasonal values were taken as reference (RR=1), RR=1.24 (95% CI: 1.049–1.475) for autumn, RR=1.86 (95%CI: 1.541–2.115) for spring and RR=2.08 (95% CI: 1.793–2.434) for winter. Air pollution and meteorological parameters should be seen as a widespread public health problem, which can trigger admission and even death due to COPD.

Introduction: Thrombocytopenia is a common clinical problem in cancer patients undergoing high-dose chemotherapy and autologous hematopoietic stem cell transplantation (HSCT). It can occur as prolonged isolated thrombocytopenia (PIT) or secondary failure of platelet recovery (SFPR) and may cause potentially fatal bleeding. However, data on the treatment of post-transplant thrombocytopenia is still lacking. Methods: We reported our practices involving 15 pediatric patients who received eltrombopag (ELT) treatment for PIT and SFPR after autologous HSCT. Results: The overall response was 78.5% (11/14), with 1 patient excluded due to noncompliance. The 12 surviving patients' median follow up was 699 days (range: 167 to 2250 d). Conclusions: Our study indicates the efficacy and safety of ELT for treating PIT and SFPR after autologous HSCT in pediatric patients. However, more studies are needed to confirm these findings in children.